CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Horizon Pharma plc - HZNP CFD

99.69
4.54%
0.25
Low: 99.67
High: 99.93
Market Trading Hours* (UTC) Open now
Closes on Monday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.25
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0308%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0137%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 104.41
Open* 99.72
1-Year Change* -0.16%
Day's Range* 99.67 - 99.67
52 wk Range 57.84-117.49
Average Volume (10 days) 1.78782
Average Volume (3 months) 55.7124
Market Cap 17511
P/E Ratio 23.8692
Shares Outstanding 226621000
Revenue 3813.11
EPS 3.23722
Dividend (Yield %) N/A
Beta 1.10695
Next Earnings Date Mar 1, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 2, 2022 104.41 1.60 1.56% 102.81 105.04 100.85
Dec 1, 2022 100.75 0.68 0.68% 100.07 104.05 99.49
Nov 30, 2022 100.15 -1.30 -1.28% 101.45 101.73 98.80
Nov 29, 2022 78.69 1.35 1.75% 77.34 78.99 77.34
Nov 28, 2022 77.92 2.11 2.78% 75.81 79.24 75.81
Nov 25, 2022 78.17 2.24 2.95% 75.93 78.30 75.93
Nov 23, 2022 77.43 0.80 1.04% 76.63 78.04 76.63
Nov 22, 2022 77.16 2.06 2.74% 75.10 77.28 75.10
Nov 21, 2022 76.63 1.97 2.64% 74.66 77.03 74.66
Nov 18, 2022 76.15 0.61 0.81% 75.54 77.46 75.48
Nov 17, 2022 75.03 0.59 0.79% 74.44 75.13 73.13
Nov 16, 2022 75.58 1.10 1.48% 74.48 76.79 74.48
Nov 15, 2022 75.96 0.42 0.56% 75.54 76.97 75.03
Nov 14, 2022 74.56 0.94 1.28% 73.62 76.33 72.13
Nov 11, 2022 74.16 0.26 0.35% 73.90 75.75 72.39
Nov 10, 2022 76.50 1.75 2.34% 74.75 77.94 74.75
Nov 9, 2022 74.83 -1.62 -2.12% 76.45 78.28 74.76
Nov 8, 2022 77.00 1.43 1.89% 75.57 78.70 75.57
Nov 7, 2022 77.56 0.68 0.88% 76.88 78.18 76.32
Nov 4, 2022 77.11 3.92 5.36% 73.19 77.44 71.21

Horizon Pharma plc Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 981.12 1056.23 1207.57 1300.03 2200.43 3226.41
Revenue 981.12 1056.23 1207.57 1300.03 2200.43 3226.41
Cost of Revenue, Total 392.001 493.368 391.301 362.175 532.695 794.512
Gross Profit 589.119 562.863 816.269 937.854 1667.73 2431.9
Total Operating Expense 1127.02 1396.67 1169.66 1232.25 1742.26 2683.28
Selling/General/Admin. Expenses, Total 603.048 655.093 692.485 697.111 973.227 1446.41
Research & Development 60.707 224.962 82.762 103.169 209.364 431.99
Unusual Expense (Income) 71.26 23.248 3.111 69.798 26.973 10.371
Operating Income -145.896 -340.44 37.911 67.776 458.17 543.127
Interest Income (Expense), Net Non-Operating -87.615 -126.783 -121.884 -87.056 -59.913 -82.091
Gain (Loss) on Sale of Assets 0 7.965 0 0
Other, Net 6.697 0.447 0.841 -0.944 3.388 1.791
Net Income Before Taxes -226.814 -458.811 -83.132 -20.224 401.645 462.827
Net Income After Taxes -165.563 -434.136 -75.772 573.02 389.796 534.491
Net Income Before Extra. Items -165.563 -434.136 -75.772 573.02 389.796 534.491
Net Income -165.563 -350.125 -38.38 573.02 389.796 534.491
Income Available to Common Excl. Extra. Items -165.563 -434.136 -75.772 573.02 389.796 534.491
Income Available to Common Incl. Extra. Items -165.563 -350.125 -38.38 573.02 389.796 534.491
Diluted Net Income -165.563 -350.125 -38.38 595.46 389.796 534.491
Diluted Weighted Average Shares 160.7 163.123 166.155 205.224 215.309 235.68
Diluted EPS Excluding Extraordinary Items -1.03026 -2.66141 -0.45603 2.90151 1.8104 2.26786
Diluted Normalized EPS -0.74203 -1.87324 -0.34412 3.13776 2.31225 2.88091
Total Extraordinary Items 84.011 37.392 0 0
Dilution Adjustment 22.44 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 342.406 832.548 1036.99 1014.46 885.245
Revenue 342.406 832.548 1036.99 1014.46 885.245
Cost of Revenue, Total 100.368 200.995 251.64 241.509 215.062
Gross Profit 242.038 631.553 785.352 772.955 670.183
Total Operating Expense 502.424 694.033 705.449 781.377 690.928
Selling/General/Admin. Expenses, Total 331.992 355.204 360.26 398.954 372.734
Research & Development 57.693 139.834 93.549 140.914 103.132
Unusual Expense (Income) 12.371 -2 0 0 0
Operating Income -160.018 138.515 331.543 233.087 194.317
Interest Income (Expense), Net Non-Operating -14.308 -22.62 -23.453 -21.71 -20.836
Other, Net 3.224 -0.262 -0.849 -0.322 -0.742
Net Income Before Taxes -171.102 115.633 307.241 211.055 172.739
Net Income After Taxes -123.351 158.117 326.543 173.182 204.261
Net Income Before Extra. Items -123.351 158.117 326.543 173.182 204.261
Net Income -123.351 158.117 326.543 173.182 204.261
Income Available to Common Excl. Extra. Items -123.351 158.117 326.543 173.182 204.261
Income Available to Common Incl. Extra. Items -123.351 158.117 326.543 173.182 204.261
Diluted Net Income -123.351 158.117 326.543 173.182 204.261
Diluted Weighted Average Shares 223.921 235.192 236.199 236.953 235.953
Diluted EPS Excluding Extraordinary Items -0.55087 0.67229 1.38249 0.73087 0.86568
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.34601 0.88029 1.42077 0.94745 0.87154
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 1046.28 1268.17 1545.82 1686.1 3070.41 2799.77
Cash and Short Term Investments 509.055 751.368 958.712 1076.29 2079.91 1580.32
Cash & Equivalents 509.055 751.368 958.712 1076.29 2079.91 1580.32
Total Receivables, Net 305.725 405.214 464.73 408.685 659.701 632.775
Accounts Receivable - Trade, Net 305.725 405.214 464.73 408.685 659.701 632.775
Total Inventory 184.98 73.07 55.29 53.802 75.283 225.73
Prepaid Expenses 39.427 31.452 41.945 97.189 199.639 290.931
Other Current Assets, Total 7.095 7.064 25.139 50.14 55.879 70.014
Total Assets 4292.06 4202.3 3941.96 4436.03 6072.62 8677.73
Property/Plant/Equipment, Total - Net 23.484 20.405 20.101 69.959 223.437 367.998
Property/Plant/Equipment, Total - Gross 30.376 34.077 39.298 95.807 271.228 403.902
Accumulated Depreciation, Total -8.319 -13.672 -19.197 -25.848 -47.791 -35.904
Goodwill, Net 445.579 426.441 413.669 413.669 413.669 1066.71
Intangibles, Net 2773.44 2447.73 1950.27 1702.63 1782.96 3840.12
Other Long Term Assets, Total 3.279 39.551 12.107 563.675 582.14 603.136
Total Current Liabilities 605.852 794.969 708.687 723.169 875.74 886.571
Accounts Payable 52.479 34.681 30.284 21.514 37.71 30.125
Accrued Expenses 542.302 742.778 673.502 691.824 821.984 819.371
Notes Payable/Short Term Debt 0 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 7.75 10.625 0 16
Other Current Liabilities, Total 3.321 6.885 4.901 9.831 16.046 21.075
Total Liabilities 3028.28 3200.99 2751.86 2250.58 2047.27 4005.33
Total Long Term Debt 1799.74 1891.03 1896.68 1352.84 1003.38 2555.23
Long Term Debt 1799.74 1891.03 1896.68 1352.84 1003.38 2555.23
Deferred Income Tax 296.568 157.945 107.768 94.247 66.474 390.455
Other Liabilities, Total 326.117 357.044 38.717 80.328 101.672 173.076
Total Equity 1263.78 1001.31 1190.11 2185.45 4025.35 4672.39
Common Stock 0.016 0.016 0.017 0.019 0.022 0.023
Additional Paid-In Capital 2119.46 2248.98 2374.97 2797.6 4245.94 4373.34
Retained Earnings (Accumulated Deficit) -848.021 -1242.12 -1178.77 -605.682 -215.886 318.605
Treasury Stock - Common -4.585 -4.585 -4.585 -4.585 -4.585 -4.585
Other Equity, Total -3.086 -0.983 -1.523 -1.905 -0.145 -14.987
Total Liabilities & Shareholders’ Equity 4292.06 4202.3 3941.96 4436.03 6072.62 8677.73
Total Common Shares Outstanding 161.621 164.401 168.86 188.018 221.337 227.377
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 1831.37 2175.38 2413.92 2799.77 2947.73
Cash and Short Term Investments 811.609 812.319 1068.55 1580.32 1643.13
Cash & Equivalents 811.609 812.319 1068.55 1580.32 1643.13
Total Receivables, Net 443.172 735.433 775.371 632.775 684.507
Accounts Receivable - Trade, Net 443.172 735.433 775.371 632.775 684.507
Total Inventory 238.306 258.676 237.434 225.73 226.524
Prepaid Expenses 275.825 280.043 250.285 290.931 303.655
Other Current Assets, Total 62.456 88.909 82.284 70.014 89.916
Total Assets 7846.61 8207.42 8608.69 8677.73 8740.34
Property/Plant/Equipment, Total - Net 226.057 305.242 362.237 367.998 390.347
Property/Plant/Equipment, Total - Gross 256.607 338.986 399.645 403.902 432.004
Accumulated Depreciation, Total -30.55 -33.744 -37.408 -35.904 -41.657
Goodwill, Net 1076.39 1069.03 1069.03 1066.71 1066.71
Intangibles, Net 4090.22 3999.71 3931.14 3840.12 3751.98
Other Long Term Assets, Total 622.576 658.054 832.364 603.136 583.572
Total Current Liabilities 773.844 852.81 854.043 886.571 825.179
Accounts Payable 42.986 51.947 50.724 30.125 67.014
Accrued Expenses 697.689 764.795 766.787 819.371 719.327
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 16 16 16 16 16
Other Current Liabilities, Total 17.169 20.068 20.532 21.075 22.838
Total Liabilities 3991.84 4133.78 4158.47 4005.33 3922.51
Total Long Term Debt 2562.52 2560.44 2557.86 2555.23 2552.74
Long Term Debt 2562.52 2560.44 2557.86 2555.23 2552.74
Deferred Income Tax 524.407 549.078 591.552 390.455 334.778
Other Liabilities, Total 131.072 171.448 155.015 173.076 209.811
Total Equity 3854.77 4073.64 4450.21 4672.39 4817.83
Common Stock 0.022 0.022 0.022 0.023 0.023
Additional Paid-In Capital 4199.82 4260.34 4310.89 4373.34 4314.65
Retained Earnings (Accumulated Deficit) -339.237 -181.12 145.423 318.605 522.866
Treasury Stock - Common -4.585 -4.585 -4.585 -4.585 -4.585
Other Equity, Total -1.253 -1.018 -1.532 -14.987 -15.122
Total Liabilities & Shareholders’ Equity 7846.61 8207.42 8608.69 8677.73 8740.34
Total Common Shares Outstanding 224.643 225.715 226.642 227.377 229.49
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -165.563 -401.585 -74.187 573.02 389.796 534.491
Cash From Operating Activities 369.456 284.34 194.543 426.332 555.688 1035.27
Cash From Operating Activities 221.665 283.244 275.729 237.157 279.451 353.751
Deferred Taxes -65.561 -132.231 -64.491 -565.537 -33.453 -101.016
Non-Cash Items 243.148 388.924 201.65 184.189 265.569 309.785
Cash Taxes Paid 22.339 2.548 53.058 9.925 15.115 97.235
Cash Interest Paid 60.817 113.79 112.468 78.044 51.863 74.353
Changes in Working Capital 135.767 145.988 -144.158 -2.497 -345.675 -61.74
Cash From Investing Activities -1370.65 -102.185 27.653 -17.857 -464.071 -2994.11
Capital Expenditures -15.725 -4.336 -4.771 -17.857 -169.852 -76.596
Other Investing Cash Flow Items, Total -1354.92 -97.849 32.424 0 -294.219 -2917.51
Cash From Financing Activities 657.074 54.276 -16.596 -290.446 904.579 1470.12
Financing Cash Flow Items 1.001 -19.451 -5.845 -16.955 -66.505 -165.964
Issuance (Retirement) of Stock, Net 3.883 2.964 16.972 351.675 972.823 73.094
Issuance (Retirement) of Debt, Net 652.19 70.763 -27.723 -625.166 -1.739 1562.99
Foreign Exchange Effects -1.21 5.316 -1.38 -0.107 7.244 -10.606
Net Change in Cash -345.326 241.747 204.22 117.922 1003.44 -499.323
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -123.351 34.766 361.309 534.491 204.261
Cash From Operating Activities -3.728 85.674 496.714 1035.27 215.791
Cash From Operating Activities 70.82 162.736 257.216 353.751 95.112
Deferred Taxes -28.771 -18.115 -147.934 -101.016 -33.896
Non-Cash Items 68.87 171.249 229.511 309.785 52.067
Cash Taxes Paid 1.201 13.435 57.178 97.235 1.496
Cash Interest Paid 18.988 32.102 61.998 74.353 28.095
Changes in Working Capital 8.704 -264.962 -203.388 -61.74 -101.753
Cash From Investing Activities -2729.5 -2815.16 -2957.27 -2994.11 -40.724
Capital Expenditures -18.333 -32.255 -59.695 -76.596 -14.198
Other Investing Cash Flow Items, Total -2711.17 -2782.91 -2897.57 -2917.51 -26.526
Cash From Financing Activities 1469.19 1468.67 1460.41 1470.12 -110.037
Financing Cash Flow Items -128.261 -141.648 -158.077 -165.964 -115.108
Issuance (Retirement) of Stock, Net 19.843 39.321 51.495 73.094 9.071
Issuance (Retirement) of Debt, Net 1577.61 1570.99 1566.99 1562.99 -4
Foreign Exchange Effects -3.998 -6.498 -10.951 -10.606 -1.921
Net Change in Cash -1268.03 -1267.32 -1011.09 -499.323 63.109
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 9.343 21173331 349532 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.852 10995581 680565 2022-09-30 LOW
Capital International Investors Investment Advisor 3.8049 8622610 957225 2022-09-30 LOW
Nuveen LLC Pension Fund 2.844 6445218 360890 2022-09-30 LOW
Paulson & Co. Inc. Hedge Fund 2.6917 6100000 -99000 2022-09-30 LOW
Janus Henderson Investors Investment Advisor/Hedge Fund 2.682 6078056 -1416298 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 2.5295 5732387 188413 2022-09-30 LOW
Avoro Capital Advisors LLC Investment Advisor/Hedge Fund 2.2615 5125000 125000 2022-09-30 LOW
JP Morgan Asset Management Investment Advisor 2.1199 4804064 117387 2022-09-30 LOW
Barclays Bank PLC Investment Advisor 1.4954 3388908 3143916 2022-09-30 MED
Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 1.3523 3064684 546194 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.3323 3019338 23963 2022-09-30 LOW
Citadel Advisors LLC Hedge Fund 1.2042 2729034 2275125 2022-09-30 HIGH
Wellington Management Company, LLP Investment Advisor/Hedge Fund 1.1653 2640849 1476491 2022-09-30 LOW
Pictet Asset Management Ltd. Investment Advisor/Hedge Fund 1.1074 2509590 274876 2022-09-30 LOW
Marshall Wace LLP Investment Advisor/Hedge Fund 1.106 2506329 2347834 2022-09-30 HIGH
Invesco Advisers, Inc. Investment Advisor 1.0269 2327172 1105630 2022-09-30 LOW
Woodline Partners LP Hedge Fund 1.0267 2326663 2088635 2022-09-30 HIGH
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.0259 2324851 206182 2021-12-31 LOW
Point72 Asset Management, L.P. Hedge Fund 0.9242 2094400 2094400 2022-09-30 HIGH

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
475000+

Traders

71000+

Active clients monthly

$51000000+

Monthly investing volume

$30000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Horizon Pharma plc Company profile

Horizon Pharma Public Limited Company
Industry: Pharmaceuticals (NEC)

Connaught House, 1St Floor
1 Burlington Road
DUBLIN
DUBLIN D04 C5Y6
IE

Income Statement

People also watch

Natural Gas

5.75 Price
-7.960% 1D Chg, %
Long position overnight fee 0.0437%
Short position overnight fee -0.0705%
Overnight fee time 22:00 (UTC)
Spread 0.005

Oil - Crude

81.45 Price
+1.490% 1D Chg, %
Long position overnight fee -0.0023%
Short position overnight fee -0.0114%
Overnight fee time 22:00 (UTC)
Spread 0.03

BTC/USD

17,204.65 Price
+0.650% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 60.00

XRP/USD

0.39 Price
+0.530% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00412

Still looking for a broker you can trust?

Join the 475.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading